Genomic imprinting

Reproductive Toxicology

Volumn 11, Issue 2-3, 1997, Pages 309-316

  Stewart, Colin L ^a,i   Pedersen, Roger ^b,j   Rotwein, Peter ^c   Bestor, Tim ^d,k   Rastan, Sohaila ^e,l   Hastie, Nick ^f   Nichols, Rob ^g,m   Mutter, George ^h  

^a HOFFMANN LA ROCHE INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MRC Clinical Research Centre   (United Kingdom)

^f WESTERN GENERAL HOSPITAL   (United Kingdom)

^g UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k The New York Presbyterian Hospital   (United States)

^l MEDICAL RESEARCH COUNCIL   (United Kingdom)

^m CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; CONFERENCE PAPER; DNA METHYLATION; EMBRYO; EMBRYOTOXICITY; GENETIC MANIPULATION; GENOME IMPRINTING; MOLECULAR GENETICS; NONHUMAN; PARTHENOGENESIS; PREIMPLANTATION EMBRYO; X CHROMOSOME INACTIVATION; ANIMAL; BECKWITH WIEDEMANN SYNDROME; CONGENITAL MALFORMATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MOUSE; NEPHROBLASTOMA; PRADER WILLI SYNDROME; RESEARCH; STEM CELL; X CHROMOSOME;

TERATOGENIC AGENT;

ABNORMALITIES; ANIMALS; BECKWITH-WIEDEMANN SYNDROME; DNA METHYLATION; DOSAGE COMPENSATION, GENETIC; FEMALE; GENOMIC IMPRINTING; HUMANS; MALE; MICE; PRADER-WILLI SYNDROME; RESEARCH; STEM CELLS; TERATOGENS; WILMS TUMOR; X CHROMOSOME;

EID: 0030990550     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(96)00213-4     Document Type: Conference Paper

References (28)

1. Solter D. Differential imprinting and expression of maternal and paternal genomes. Annu Rev Genet. 1988;22:127-46.
2. Barton S, Surani M, Norris M. Role of paternal and maternal genomes in mouse development. Nature. 1984;311:374-6.
3. Cattanach BM, Beechey CV. Autosomal and X-chromosomal imprinting. Development (Suppl). 1990;63-72.
4. John RM, Surani MA. Imprinted genes and the regulation of gene expression by epigenetic inheritance. Curr Opin Cell Biol. 1996;8:348-53.
5. Haig D, Graham C. Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell. 1991;64:1015-46.
6. Surani MAH, Barton SC, Norris ML. Nuclear transplantation in the mouse: heritable differences between parental genomes after activation of the embryonic genome. Cell. 1986;45:127-36.
7. Barton SC, Ferguson-Smith AC, Fundele R, Surani MA. Influence of paternally imprinted genes on development. Development. 1991;113:679-88.
8. Mann JR, Stewart CL. Development to term of mouse androgenetic aggregation chimeras. Development 1991;113:1325-33.
9. Generoso WM. Mouse models for understanding human developmental anomalies. Prog Clin Biol Res. 1990;340C:151-7.
10. Froesch FR, Schmid C, Schwander J, Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol. 1985;47:443-67.
11. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev. 1989;10:68-91.
12. Humbel RE. Insulin-like growth factors I and II. Eur J Biochem. 1990;190:445-462.
13. Daughaday WH. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology. 1990;127:1-4.
14. Barlow DP, Stoger R, Herrmann BG, Saito K, Schweifer N. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme Locus. Nature. 1991;349:84-7.
15. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying and insulin-like growth factor II gene disrupted by gene targeting. Nature. 1990;345:78-80.
16. DeChiara TM, Robertson EJ, Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 1991;64:849-59.
17. Lyon MF. X-chromosome inactivation as a system of gene dosage compensation to regulate gene expression. Prog Nucleic Acid Res. 1989;36:119-30.
18. Brockdorff N, Ashworth A, Kay GF, Cooper P, Smith S, McCabe VM, Norris DP, Penny GD, Patel D, Rastan S. Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. Nature. 1991;351:329-31.
19. Rastan S, Brown SD. The search for the mouse X-chromosome inactivation centre. Genet Res. 1990;56:99-106.
20. Kay GF, Penny GD, Patel D, Ashworth A, Brockdorff N, Rastan S. Expression of Xist during mouse development suggests a role in the initiation of X chromosome inactivation. Cell. 1993;72:171-82.
21. Solter D. Relevance of genomic imprinting to human diseases. Curr Opin Biotechnol. 1992;(6):632-6.
22. Genest D, Laborde O, Berkowitz R, Goldstein D, Bernstein M, Lage J. A clinicopathologic study of 153 cases of complete hyda-tidiform mole (1980-1990): histologic grade lacks prognostic significance. Obstet Gynecol. 1991;78:402-9.
23. Grimes DA. Epidemiology of gestational trophoblastic disease. Am J Obstet Gynecol. 1984;150:309-18.
24. Little M, Van Heyningen V, Hastie N. Dads and disomy and disease. Nature. 1991;351:609-10.
25. Driscoll DJ, Waters MF, Williams CA, Zori RT, Glenn CC, Avidano KM, Nicholls RDA. DNA methylation imprint, determined by the sex of the parent, distinguishes the Angelman and Prader-Willi syndromes. Genomics. 1992;13:917-24.
26. Antequera F, Boyes J, Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell. 1990;62:503-14.
27. Bird A. The essentials of DNA methylation. Cell. 1992;70:5-8.
28. Bestor TH. DNA methylation: evolution of a bacterial immune function into regulator of gene expression and genome structure in higher eukaryotes. Philos Trans R Soc Lond B Biol Sci. 1990;326:179-87.